Potential roles of interleukin-17A in the development of skin fibrosis in mice.
about
Medical Therapy of Fibrostenotic Crohn's DiseaseFibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyTh17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitisSpotlight on tocilizumab and its potential in the treatment of systemic sclerosisPolymorphisms in interleukin 17A gene and coal workers' pneumoconiosis risk in a Chinese populationHigh IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathwayCentral role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosisDeficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage.Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice.Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary CirrhosisThe role of interleukin 17 in Crohn's disease-associated intestinal fibrosisA CASE OF BEHÇET'S DISEASE AND SYSTEMIC SCLEROSIS DEVELOPING AFTER AN EARTHQUAKE DISASTER.Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.The role of the acquired immune response in systemic sclerosis.Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica.Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activationIL-17 in the rheumatologist's line of sight.A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis.Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.IL-17 and related cytokines involved in systemic sclerosis: Perspectives.Secukinumab-induced interstitial pneumonia in a patient with psoriasis vulgaris.Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model.Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt/β-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model.Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosisAn orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
P2860
Q26777724-F0F65405-A1D5-44F9-A135-7C17A8675BC2Q26801150-CA3F5DD2-8950-49D5-A1D6-AF3F417E626CQ28067738-3E9418B1-DDB4-45D3-AEC1-FED5F931256EQ28073706-DAC3B8A9-E6DA-41BE-B4E9-11EDF2519E72Q28384688-C715A631-57CD-4AD3-8D30-49A343863A4CQ34066564-89DA60A5-B2C0-4B17-9FB8-5D2BE4998F36Q34364890-B18AA848-242D-4C69-8176-441D6A4DDEFBQ34504710-0ADC8675-1FCC-4D34-8C54-84EA25751AD3Q35078513-A1733173-6A28-46A6-A36C-7145FA1469CEQ35276739-1B7E371E-43E8-475D-866A-E4C006222737Q36242603-C3F085C0-D98E-42E8-913E-C00E43046771Q36260811-F231135B-0B2B-4906-B9B1-C8A7E46EE16DQ36296731-64310CDA-C87D-455C-90A7-6ECA31D3B481Q37026138-4AC97A18-ADBB-49CA-99CB-E439338EFAE5Q37070931-8FC1A4E0-D23E-4EB0-B079-88CD80FCC19DQ37461051-B75FF472-89FD-46EB-99A7-C775460B79FEQ37691158-85A00278-4451-494D-82C5-94875328512DQ38543690-283C74D6-D494-4E58-BBF2-D297F891BD30Q41117896-84E22D8E-13A5-41CE-B56E-A413749F8BA9Q41519827-1B13B4E2-CB85-4B10-95DE-47F485C7DC5FQ41617768-C88A086D-8B5A-430C-9210-D61A8AC4B5F2Q41890076-0E598677-1A60-40A1-9BBD-09EA1E3ED0DEQ42615760-EEBCE755-A2A1-4BDD-876E-AB49CEC478E1Q46474228-C09678BE-255B-463A-864F-1AB7B2749D38Q47774368-D36F2E08-8FF5-4FE4-AC95-08B8CC8E59D1Q47812924-E3935E62-6F6C-4265-9A10-E82965146384Q49989946-4A4D5F9C-C519-4B83-A752-F1039BA662DEQ50300727-C25DAE14-2C2B-43CD-AF2E-10DA7ABBBC3BQ54093499-6F078A5D-5492-47F3-BB22-DFB1E376529BQ54189017-A8611065-9A42-43BE-ADAA-4332C2ADD79DQ58411438-321E5B66-C4B0-48C0-8B4A-EB3B8A8E1EA1Q58797878-B9443903-F9FF-4507-9DA8-7EAFB41566A6
P2860
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
@en
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
@nl
type
label
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
@en
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
@nl
prefLabel
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
@en
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
@nl
P2093
P2860
P50
P356
P1476
Potential roles of interleukin-17A in the development of skin fibrosis in mice.
@en
P2093
Kazuhiko Takehara
Manabu Fujimoto
Minoru Hasegawa
Yasuhito Hamaguchi
Yoshinobu Okamoto
P2860
P304
P356
10.1002/ART.34643
P577
2012-11-01T00:00:00Z